Your browser doesn't support javascript.
loading
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.
O'Mahony, Denise G; Ramus, Susan J; Southey, Melissa C; Meagher, Nicola S; Hadjisavvas, Andreas; John, Esther M; Hamann, Ute; Imyanitov, Evgeny N; Andrulis, Irene L; Sharma, Priyanka; Daly, Mary B; Hake, Christopher R; Weitzel, Jeffrey N; Jakubowska, Anna; Godwin, Andrew K; Arason, Adalgeir; Bane, Anita; Simard, Jacques; Soucy, Penny; Caligo, Maria A; Mai, Phuong L; Claes, Kathleen B M; Teixeira, Manuel R; Chung, Wendy K; Lazaro, Conxi; Hulick, Peter J; Toland, Amanda E; Pedersen, Inge Sokilde; Neuhausen, Susan L; Vega, Ana; de la Hoya, Miguel; Nevanlinna, Heli; Dhawan, Mallika; Zampiga, Valentina; Danesi, Rita; Varesco, Liliana; Gismondi, Viviana; Vellone, Valerio Gaetano; James, Paul A; Janavicius, Ramunas; Nikitina-Zake, Liene; Nielsen, Finn Cilius; van Overeem Hansen, Thomas; Pejovic, Tanja; Borg, Ake; Rantala, Johanna; Offit, Kenneth; Montagna, Marco; Nathanson, Katherine L; Domchek, Susan M.
Afiliación
  • O'Mahony DG; Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, 2371, Cyprus.
  • Ramus SJ; Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, 2371, Cyprus.
  • Southey MC; School of Clinical Medicine, University of New South Wales Medicine and Health, University of New South Wales Sydney, Sydney, NSW, 2052, Australia.
  • Meagher NS; Adult Cancer Program, Lowy Cancer Research Centre, University of New South Wales Sydney, Sydney, NSW, 2052, Australia.
  • Hadjisavvas A; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, 3168, Australia.
  • John EM; Department of Clinical Pathology, The University of Melbourne, Melbourne, VIC, 3010, Australia.
  • Hamann U; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, 3004, Australia.
  • Imyanitov EN; School of Clinical Medicine, University of New South Wales Medicine and Health, University of New South Wales Sydney, Sydney, NSW, 2052, Australia.
  • Andrulis IL; Adult Cancer Program, Lowy Cancer Research Centre, University of New South Wales Sydney, Sydney, NSW, 2052, Australia.
  • Sharma P; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, NSW, Australia.
  • Daly MB; Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, 2371, Cyprus.
  • Hake CR; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, 94305, USA.
  • Weitzel JN; Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94304, USA.
  • Jakubowska A; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany.
  • Godwin AK; N.N. Petrov Institute of Oncology, St. Petersburg, 197758, Russia.
  • Arason A; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, M5G 1×5, Canada.
  • Bane A; Department of Molecular Genetics, University of Toronto, Toronto, ON, M5S 1A8, Canada.
  • Simard J; Department of Internal Medicine, Division of Medical Oncology, University of Kansas Medical Center, Westwood, KS, 66205, USA.
  • Soucy P; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA.
  • Caligo MA; Waukesha Memorial Hospital-Pro Health Care, Waukesha, WI, 53188, USA.
  • Mai PL; The University of Kansas Cancer Center, Kansas City, MO, 66160, USA.
  • Claes KBM; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, 171-252, Poland.
  • Teixeira MR; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, 171-252, Poland.
  • Chung WK; Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS, 66160, USA.
  • Lazaro C; Department of Pathology, Landspitali University Hospital, Reykjavik, 101, Iceland.
  • Hulick PJ; BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, 101, Iceland.
  • Toland AE; Department of Pathology & Molecular Medicine, Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, ON, L8V 1C3, Canada.
  • Pedersen IS; Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval Research Center, Québec City, QC, G1V 4G2, Canada.
  • Neuhausen SL; SOD Genetica Molecolare, University Hospital, Pisa, 56126, Italy.
  • Vega A; Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.
  • de la Hoya M; Centre for Medical Genetics, Ghent University, Gent, 9000, Belgium.
  • Nevanlinna H; Department of Laboratory Genetics, Portuguese Oncology Institute of Porto (IPO Porto)/Comprehensive Cancer Center, Porto, 4200-072, Portugal.
  • Dhawan M; School of Medicine and Biomedical Sciences Institute (ICBAS), University of Porto, Porto, 4050-013, Portugal.
  • Zampiga V; Departments of Pediatrics and Medicine, Columbia University, New York, NY, 10032, USA.
  • Danesi R; Hereditary Cancer Program, ONCOBELL-IDIBELL-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, 08908, Spain.
  • Varesco L; Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL, 60201, USA.
  • Gismondi V; The University of Chicago Pritzker School of Medicine, Chicago, IL, 60637, USA.
  • Vellone VG; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, 43210, USA.
  • James PA; Molecular Diagnostics, Aalborg University Hospital, Aalborg, 9000, Denmark.
  • Janavicius R; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, 9000, Denmark.
  • Nikitina-Zake L; Department of Clinical Medicine, Aalborg University, Aalborg, 9000, Denmark.
  • van Overeem Hansen T; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, 91010, USA.
  • Pejovic T; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, 28029, Spain.
  • Borg A; Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, 15706, Spain.
  • Rantala J; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, 15706, Spain.
  • Offit K; Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, 28040, Spain.
  • Montagna M; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, 00290, Finland.
  • Nathanson KL; Cancer Genetics and Prevention Program, University of California San Francisco, San Francisco, CA, 94143-1714, USA.
  • Domchek SM; Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
Br J Cancer ; 128(12): 2283-2294, 2023 06.
Article en En | MEDLINE | ID: mdl-37076566
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias de la Mama Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Br J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Chipre Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias de la Mama Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Br J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Chipre Pais de publicación: Reino Unido